ORIFARM PI A/S: Financial statements 2020
CVR: 27347177
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
ORIFARM PI A/S (CVR 27347177) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -57,000 and a net result of DKK 208,734,000 compared with DKK 191,779,000 the year before. Equity in the 2020 report amounted to DKK 563,785,000. The solvency ratio was 85.5%.
- Gross Profit
- DKK -57,000
- Profit/Loss
- DKK 208,734,000
- Equity
- DKK 563,785,000
- Total Assets
- DKK 659,122,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -57K | 208.7M | 563.8M | 0 |
| 2019 | - | -71K | 191.8M | 554.4M | - |
| 2018 | - | -169K | 149M | 502.6M | - |
| 2017 | - | -174K | 99.7M | 357.5M | - |
| 2016 | - | -203K | 50.1M | 256.8M | - |
Official annual report
How creditworthy is ORIFARM PI A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
ORIFARM PI A/S has published its annual report for 2019. Gross profit came to DKK -71,000, and the net result was DKK 191,779,000.
About ORIFARM PI A/S
ORIFARM PI A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Finansielle holdingselskaber. The company was previously named ORIFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -446,000 and a net result of DKK 298,665,000 compared with DKK 320,939,000 the year before. Equity in the 2025 report amounted to DKK 1,391,995,000.